Literature DB >> 9531290

Activation of lyn, blk, and btk but not syk in CD72-stimulated B lymphocytes.

C Venkataraman1, N Muthusamy, S Muthukkumar, S Bondada.   

Abstract

CD72 is a B cell-specific glycoprotein that has been shown to be important for activation of mature B cells. Previously we showed that some of the early signaling events, such as calcium mobilization and phospholipase-gamma activation, were similar in B cell Ag receptor (BCR)- and CD72-stimulated B cells and that BCR- but not CD72-mediated early signaling events were blocked by protein kinase A activation. The present report shows that CD72 ligation induces a variety of tyrosine-phosphorylated proteins, most of which were of the same molecular mass as those seen in anti-IgM-treated B cells, except for a 72-kDa protein. Further analysis showed that the tyrosine kinases lyn and blk were activated in CD72-ligated B cells. Interestingly, the non-src kinase syk was not activated in CD72-stimulated cells whereas the tec family kinase btk was activated in both CD72- and BCR-stimulated B cells. Furthermore, B cells from xid mice were unresponsive to CD72-induced proliferation, indicating an essential role for btk in CD72-induced signaling events. Surprisingly, tyrosine phosphorylation of phospholipase C-gamma2 was normal in CD72-stimulated cells in spite of a lack of activation of syk. Furthermore, B cell proliferation through CD72 was blocked by the immunosuppressive agents cyclosporin A and FK506, indicating the important role for Ca2+-regulated activation events similar to BCR-stimulated cells. We propose that btk can substitute for syk in inducing phospholipase C-gamma2 tyrosine phosphorylation and initiating calcium mobilization in CD72-stimulated B lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9531290

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

Review 1.  Positive and negative roles of CD72 in B cell function.

Authors:  Hsin-Jung Wu; Subbarao Bondada
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  The modulation of B7.2 and B7.1 on B cells by immunosuppressive agents.

Authors:  O Jirapongsananuruk; D Y Leung
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

3.  c-Jun N-terminal kinase (JNK) is required for survival and proliferation of B-lymphoma cells.

Authors:  Murali Gururajan; Roger Chui; Anbu K Karuppannan; Jiyuan Ke; C Darrell Jennings; Subbarao Bondada
Journal:  Blood       Date:  2005-05-12       Impact factor: 22.113

4.  CD72 polymorphism associated with child-onset of idiopathic thrombocytopenic purpura in Chinese patients.

Authors:  Jianhui Xu; Shihong Lu; Jie Tao; Zeping Zhou; Zhenping Chen; Ying Huang; Renchi Yang
Journal:  J Clin Immunol       Date:  2008-05       Impact factor: 8.317

5.  CD72, a coreceptor with both positive and negative effects on B lymphocyte development and function.

Authors:  Hsin-Jung Wu; Subbarao Bondada
Journal:  J Clin Immunol       Date:  2008-12-06       Impact factor: 8.542

6.  Targeting BTK for the treatment of FLT3-ITD mutated acute myeloid leukemia.

Authors:  Genevra Pillinger; Amina Abdul-Aziz; Lyubov Zaitseva; Matthew Lawes; David J MacEwan; Kristian M Bowles; Stuart A Rushworth
Journal:  Sci Rep       Date:  2015-08-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.